MO-GCN: A multi-omics graph convolutional network for discriminative analysis of schizophrenia
Haiyuan Wang,
No information about this author
Runlin Peng,
No information about this author
Yuanyuan Huang
No information about this author
et al.
Brain Research Bulletin,
Journal Year:
2025,
Volume and Issue:
221, P. 111199 - 111199
Published: Jan. 7, 2025
The
methodology
of
machine
learning
with
multi-omics
data
has
been
widely
adopted
in
the
discriminative
analyses
schizophrenia,
but
most
these
studies
ignored
cooperative
interactions
and
topological
attributes
networks.
In
this
study,
we
constructed
three
types
brain
graphs
(BGs),
gut
(GGs),
nine
brain-gut
combined
(BGCGs)
for
each
individual.
We
proposed
a
novel
graph
convolutional
network
(MO-GCN)
an
attention
mechanism
to
construct
classification
model
by
integrating
all
BGCGs.
also
identified
important
features
using
Topk
pooling
layer
analyzed
their
correlations
Positive
Negative
Syndrome
Scale
(PANSS)
MATRICS
Consensus
Cognitive
Battery
(MCCB)
scores.
results
showed
that
MO-GCN
BGCGs
outperformed
GCN
models
either
BGs
or
GGs.
particular,
accuracy
best
5-fold
cross-validation
reached
84.0%.
Interpretability
analysis
revealed
top
10
were
primarily
from
hippocampus,
olfactory,
fusiform
pallidum,
which
involved
systems
memory,
emotion.
Dorea,
Ruminococcus,
Subdoligranulum
Clostridium,
etc.
Moreover,
significantly
correlated
PANSS
MCCB
scores,
respectively.
conclusion,
can
effectively
improve
performance
provide
potential
microbiota-brain
perspective
understanding
schizophrenia.
Language: Английский
Inulin alleviates chronic ketamine-induced impairments in memory and prepulse inhibition by regulating the gut microbiota, inflammation, and kynurenine pathway
Zhilong Xu,
No information about this author
Haoyang Lu,
No information about this author
Chen Hu
No information about this author
et al.
International Journal of Biological Macromolecules,
Journal Year:
2025,
Volume and Issue:
294, P. 139503 - 139503
Published: Jan. 5, 2025
Language: Английский
The role of ferroptosis and oxidative stress in cognitive deficits among chronic schizophrenia patients: a multicenter investigation
Zhenlei Peng,
No information about this author
Qiyu Jia,
No information about this author
Junxiong Mao
No information about this author
et al.
Schizophrenia,
Journal Year:
2025,
Volume and Issue:
11(1)
Published: Jan. 11, 2025
Oxidative
stress
(OS)
is
crucial
in
schizophrenia
(SCZ)
pathology.
Ferroptosis,
a
recently
discovered
cell
death
pathway
linked
to
OS,
might
contribute
the
development
of
SCZ.
This
study
investigated
association
between
ferroptosis
markers
and
cognitive
impairments
chronic
SCZ
patients.
A
retrospective
analysis
was
conducted
on
204
patients
with
deficits
216
healthy
controls
(HC)
matched
for
relevant
characteristics.
Plasma
levels
OS
markers,
including
iron,
ferritin
(FE),
transferrin
(TF),
glutathione
peroxidase
4
(GPX4),
long-chain
acyl-CoA
synthetase
(ACSL4),
(GSH),
sirtuin
1
(SIRT1),
nuclear
factor
erythroid
2-related
2
(Nrf2),
malondialdehyde
(MDA),
superoxide
dismutase
(SOD)
were
measured.
Standardized
assessments
like
positive
negative
syndrome
scale
(PANSS),
Montreal
Cognitive
Assessment
(MoCA)
used
evaluate
psychiatric
symptoms,
function.
showed
significant
differences
compared
HC
group
(P
<
0.01).
Multiple
linear
regression
revealed
that
decreased
GSH
iron
levels,
along
elevated
SOD
significantly
associated
overall
severity
symptoms.
Additionally,
reduced
GPX4
increased
ACSL4
FE
symptoms
impairments.
Notably,
emerged
as
key
predictor
function
abstraction
language
domains.
Our
alterations
altered
plasma
GPX4,
GSH,
ACSL4,
FE,
patients,
which
indicate
close
biomarkers
observed
these
individuals.
Language: Английский
Progress in the study of oxidative stress damage in patients with schizophrenia: challenges and opportunities
K Zhang,
No information about this author
Lijing Zou,
No information about this author
Yi Cai
No information about this author
et al.
Frontiers in Psychiatry,
Journal Year:
2025,
Volume and Issue:
16
Published: Feb. 21, 2025
Schizophrenia
is
a
serious
psychiatric
disorder
of
multifactorial
triggers,
with
lifetime
prevalence
about
1%
in
all
countries
the
world,
slightly
higher
males
than
females,
and
peak
incidence
between
ages
15-35
years
old,
poor
prognosis
for
most
patients,
which
imposes
heavy
burden
on
society
family.
Early
intervention
important
regression
patients.
More
more
studies
have
found
that
imbalance
oxidation
antioxidant,
persistent
damage
to
brain
by
oxidative
stress
play
an
role
occurrence
development
schizophrenia.
Antioxidants,
as
additive
therapy,
improving
symptoms
well
preventing
relapse
patients
This
paper
intends
address
pathogenesis
injury
schizophrenia,
significance
treatment
Language: Английский
Investigating the Effect of N-Acetyl Cysteine on Positive, Negative, and Cognitive Symptoms of Patients with Schizophrenia: A Clinical Trial
Iranian Journal of Psychiatry and Behavioral Sciences,
Journal Year:
2025,
Volume and Issue:
19(1)
Published: Feb. 9, 2025
Background:
Recent
studies
have
identified
oxidative
stress
as
a
potential
neurobiological
contributor
to
the
development
of
schizophrenia.
N-acetylcysteine
(NAC)
is
recognized
for
its
potent
antioxidant
and
neuroprotective
properties.
Objectives:
This
study
aimed
evaluate
efficacy
NAC
in
reducing
treatment
Methods:
randomized,
double-blind,
placebo-controlled,
parallel-group
involved
35
patients
with
Patients
case
group
received
600
mg
once
daily
addition
their
routine
treatment,
while
control
continued
placebo
instead
NAC.
Assessments
were
conducted
using
Scale
Assessment
Positive
Symptoms
(SAPS),
Negative
(SANS),
neuropsychiatry
unit
cognitive
assessment
tool
(NUCOG)
at
baseline,
1
2
months
post-treatment.
Results:
resulted
significant
improvement
SAPS
NUCOG
indices,
well
an
increase
peripheral
glutathione
(GSH)
levels
(P
<
0.05).
Continued
use
second
month
positively
affected
particularly
Visuo-constructional
variable.
No
impact
on
SANS
was
observed.
The
limited
side
effects
during
period
suggest
it
safe
practical
option.
Conclusions:
add-on
therapy
significantly
improved
positive
symptoms
functions
schizophrenia
but
did
not
affect
negative
symptoms.
Language: Английский
Altered serum glutathione disulfide levels in acute relapsed schizophrenia are associated with clinical symptoms and response to electroconvulsive therapy
Li Xu,
No information about this author
Ping Yu,
No information about this author
Haidong Yang
No information about this author
et al.
BMC Psychiatry,
Journal Year:
2025,
Volume and Issue:
25(1)
Published: March 14, 2025
The
pathophysiological
mechanisms
of
schizophrenia
are
complex
and
not
fully
elucidated.
This
study
aimed
to
investigate
changes
total
glutathione
(T-GSH),
disulfide
(GSSG),
reduced
(GSH),
the
GSH/GSSG
ratio
before
after
electroconvulsive
therapy
(ECT)
for
patients
with
acute
relapse
associations
clinical
symptoms.
cohort
included
110
55
healthy
controls.
All
received
8–10
sessions
ECT.
Clinical
symptoms
were
assessed
using
Positive
Negative
Syndrome
Scale
(PANSS).
As
compared
controls,
had
decreased
baseline
GSSG
levels
(t
=
-2.115,
p
0.036)
elevated
ratios
2.141,
0.034).
Baseline
negatively
correlated
both
PANSS
scores
(beta
-0.369,
t
-4.108,
<
0.001)
positive
symptom
-0.332,
-3.730,
0.001),
while
positively
improvements
in
(r
0.392,
0.293,
0.005)
ECT
treatment.
In
treatment
responders,
significantly
increased
-2.817,
0.006)
4.474,
as
ECT,
T-GSH
(B
0.734,
OR
2.083,
95%CI:1.287–3.372,
0.003),
-2.720,
0.066,
95%CI:0.011–0.390,
-1.013,
0.363,
95%CI:0.142–0.930,
0.035)
predictive
improvement.
Patients
exhibit
significant
redox
imbalance,
may
serve
a
potential
biomarker
evaluate
predict
outcomes.
Language: Английский
High-cellulose diet ameliorates cognitive impairment by modulating gut microbiota and metabolic pathways in mice
Journal of Nutrition,
Journal Year:
2025,
Volume and Issue:
unknown
Published: April 1, 2025
Language: Английский
Exploring the relationship between the gut microbiota and cognitive function in schizophrenia patients with distinct weights
Baoyuan Zhu,
No information about this author
Liqin Liang,
No information about this author
Yuanyuan Huang
No information about this author
et al.
Schizophrenia Research,
Journal Year:
2025,
Volume and Issue:
280, P. 103 - 113
Published: April 24, 2025
Language: Английский
Exploratory Analysis of Gut Microbiota Profile in Duchenne Muscular Dystrophy (DMD) Patients with Intellectual Disability
Molecular Neurobiology,
Journal Year:
2025,
Volume and Issue:
unknown
Published: May 5, 2025
Abstract
This
study
investigates
the
differences
in
gut
microbiota
composition
between
DMD
patients
with
(DMD
+)
and
without
−)
intellectual
disability
(ID)
its
potential
role
cognitive
outcomes.
In
this
study,
we
assessed
50
genetically
confirmed
(median
age
13.1
years)
using
16S
rRNA
gene
sequencing.
Cognitive
assessment
was
performed
Wechsler
Intelligence
Scales,
ID
defined
as
an
IQ
<
70.
Stool
samples
were
analyzed,
statistical
methods
used
to
assess
alpha-
beta-diversity.
Thirty-four
percent
of
had
ID.
No
significant
found
alpha-diversity
or
Firmicutes/Bacteroidetes
ratio.
However,
beta-diversity
analysis
revealed
+
−
groups,
including,
,
increased
abundance
Propionibacterium
Bifidobacterium
a
reduction
Bulleidia
.
These
bacteria
are
involved
metabolic
pathways
that
can
influence
neurological
health
through
gut-brain
axis,
particularly
via
production
short-chain
fatty
acids.
While
these
preliminary
findings
suggest
possible
association
profile
impairment
DMD,
further
research
is
needed
explore
causal
relationship
consider
microbiota-targeted
therapeutic
strategies.
Language: Английский
Primary Prevention Strategy for Non-Communicable Diseases (NCDs) and Their Risk Factors: The Role of Intestinal Microbiota
Itzel Ivonn López-Tenorio,
No information about this author
Óscar Rodrigo Aguilar-Villegas,
No information about this author
Yoshua Espinoza-Palacios
No information about this author
et al.
Biomedicines,
Journal Year:
2024,
Volume and Issue:
12(11), P. 2529 - 2529
Published: Nov. 5, 2024
Non-communicable
diseases
(NCDs)
are
the
leading
cause
of
morbidity
and
mortality
worldwide.
These
conditions
have
numerous
health
consequences
significantly
impact
patients'
lifestyles.
Effective
long-term
treatment
is
essential
since
NCDs
irreversible.
Therefore,
primary
healthcare
must
be
both
exclusive
highest
quality,
ensuring
comprehensive
care.
The
goal
should
to
improve
quality
life
with
a
focus
on
patients,
families,
communities,
as
most
these
can
prevented
controlled,
although
not
cured.
Several
factors
been
linked
individual
health,
including
social,
cultural,
economic
aspects,
lifestyle,
certain
environmental
factors,
work,
that
positive
or
negative
effects.
More
variables
may
contribute
onset
NCDs,
which
defined
by
their
chronic
nature,
propensity
for
prolongation,
generally
slow
rate
progression.
Examples
include
hypertension,
type
2
diabetes
(T2D),
dyslipidemia,
fatty
liver
disease
metabolic
dysfunction.
has
associated
an
imbalance
in
microbial
niches,
such
gut,
hosts
billions
microorganisms
performing
multiple
functions,
production
metabolites
like
bile
acids
(BAs),
short-chain
(SCFAs),
trimethylamine
N-oxide
(TMAO).
lifestyle
changes
personal
habits
gut
microbiota
(GM),
potentially
preventing
metabolism.
highly
prevalent
worldwide,
prompting
increased
attention
strategies
modifying
intestinal
(IM).
Approaches
probiotics,
prebiotics,
synbiotics,
fecal
transplantation
(FMT)
demonstrated
improvements
individuals
conditions.
Additionally,
adoption
healthy
IM
help
prevent
related
main
aim
this
review
analyze
understand
importance
intervention
prevention
non-communicable
diseases.
R3:A1.
Language: Английский